These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34648626)

  • 1. Interpretation of Abnormal Dexamethasone Suppression Test is Enhanced With Use of Synchronous Free Cortisol Assessment.
    Genere N; Kaur RJ; Athimulam S; Thomas MA; Nippoldt T; Van Norman M; Singh R; Grebe S; Bancos I
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e1221-e1230. PubMed ID: 34648626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas.
    Reimondo G; Allasino B; Bovio S; Saba L; Ardito A; Angeli A; Terzolo M
    J Endocrinol Invest; 2011 Jan; 34(1):e1-5. PubMed ID: 20634637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test.
    Ueland GÅ; Methlie P; Kellmann R; Bjørgaas M; Åsvold BO; Thorstensen K; Kelp O; Thordarson HB; Mellgren G; Løvås K; Husebye ES
    Eur J Endocrinol; 2017 Jun; 176(6):705-713. PubMed ID: 28298353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.
    Vieira-Correa M; Giorgi RB; Oliveira KC; Hayashi LF; Costa-Barbosa FA; Kater CE
    J Endocrinol Invest; 2019 Dec; 42(12):1435-1442. PubMed ID: 31456173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early assessment of postoperative adrenal function is necessary after adrenalectomy for mild autonomous cortisol secretion.
    Foster T; Bancos I; McKenzie T; Dy B; Thompson G; Lyden M
    Surgery; 2021 Jan; 169(1):150-154. PubMed ID: 32693952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation.
    Ceccato F; Artusi C; Barbot M; Lizzul L; Pinelli S; Costantini G; Niero S; Antonelli G; Plebani M; Scaroni C
    J Endocrinol Invest; 2020 Aug; 43(8):1105-1113. PubMed ID: 32060745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-day low-dose dexamethasone suppression test more accurate than overnight 1-mg in women taking oral contraceptives.
    Carton T; Mathieu E; Wolff F; Bouziotis J; Corvilain B; Driessens N
    Endocrinol Diabetes Metab; 2021 Jul; 4(3):e00255. PubMed ID: 34277979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
    Araujo-Castro M; Hanzu FA; Pascual-Corrales E; García Cano AM; Marchan M; Escobar-Morreale HF; Valderrabano P; Casals G
    Endocrine; 2023 Oct; 82(1):161-170. PubMed ID: 37351760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low DHEAS: A Sensitive and Specific Test for the Detection of Subclinical Hypercortisolism in Adrenal Incidentalomas.
    Dennedy MC; Annamalai AK; Prankerd-Smith O; Freeman N; Vengopal K; Graggaber J; Koulouri O; Powlson AS; Shaw A; Halsall DJ; Gurnell M
    J Clin Endocrinol Metab; 2017 Mar; 102(3):786-792. PubMed ID: 27797672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
    Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New diagnostic criteria of adrenal subclinical Cushing's syndrome: opinion from the Japan Endocrine Society.
    Yanase T; Oki Y; Katabami T; Otsuki M; Kageyama K; Tanaka T; Kawate H; Tanabe M; Doi M; Akehi Y; Ichijo T
    Endocr J; 2018 Apr; 65(4):383-393. PubMed ID: 29576599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome.
    Putignano P; Bertolini M; Losa M; Cavagnini F
    J Endocrinol Invest; 2003 Jun; 26(6):539-44. PubMed ID: 12952368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cushing's Syndrome: Screening and Diagnosis.
    Ceccato F; Boscaro M
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):209-15. PubMed ID: 27160717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Method-Specific Cortisol and Dexamethasone Thresholds Increase Clinical Specificity of the Dexamethasone Suppression Test for Cushing Syndrome.
    Vogg N; Kurlbaum M; Deutschbein T; Gräsl B; Fassnacht M; Kroiss M
    Clin Chem; 2021 Jul; 67(7):998-1007. PubMed ID: 33997885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overnight 1-mg Dexamethasone Suppression Test for Screening Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS): What Happens when Serum Dexamethasone Is Below Cutoff? How Frequent Is it?
    Farinelli DG; Oliveira KC; Hayashi LF; Kater CE
    Endocr Pract; 2023 Dec; 29(12):986-993. PubMed ID: 37734596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrepancies in results of low-and high-dose dexamethasone suppression tests for diagnosing preclinical Cushing's syndrome.
    Katabami T; Obi R; Shirai N; Naito S; Saito N
    Endocr J; 2005 Aug; 52(4):463-9. PubMed ID: 16127216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of screening tests for Cushing's syndrome in an overweight and obese population.
    Baid SK; Rubino D; Sinaii N; Ramsey S; Frank A; Nieman LK
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3857-64. PubMed ID: 19602562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of the dexamethasone suppression test for the prediction of autonomous cortisol secretion-related comorbidities in adrenal incidentalomas.
    Araujo-Castro M; Parra Ramírez P; Robles Lázaro C; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
    Hormones (Athens); 2021 Dec; 20(4):735-744. PubMed ID: 34273083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparing overnight dexamethasone suppression test, urine free cortisol, and midnight serum cortisol for the initial diagnosis of Cushing' s syndrome].
    Tang TJ; Liu YP; Yu YR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):764-8. PubMed ID: 24325108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjects.
    Carson SW; Halbreich U; Yeh CM; Asnis G; Goldstein S
    Biol Psychiatry; 1988 Sep; 24(5):569-77. PubMed ID: 3167145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.